Successful management of acute myeloid leukemia transformed from myelodysplastic syndromes in an elderly patient aged over 80 years old by ultralow dose decitabine combined with amifostine and autologous CIK cells.
Departments of Geriatric Hematology, Chinese PLA General Hospital, Fuxing Road 28, Handian District, Beijing, 100853, China.
Bo
B
Yang
Hai-tao
HT
Wang
Li-li
LL
Cai
Yu
Y
Zhao
Xiao-hua
XH
Chi
Hong-li
HL
Zhu
Hai-hong
HH
Ran
Yang
Y
Yang
Rui-li
RL
Yu
Song-wei
SW
Li
Xue-chun
XC
Lu
D000369:Aged, 80 and over; D004999:Amifostine / Q000008:administration & dosage*; D001374:Azacitidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002478:Cells, Cultured; D003131:Combined Modality Therapy / Q000379:methods; D055612:Cytokine-Induced Killer Cells / Q000637:transplantation*; D000077209:Decitabine; D019468:Disease Management; D018450:Disease Progression; D004359:Drug Therapy, Combination; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000628:therapy*; D014182:Transplantation, Autologous
D000077209:Decitabine; D004999:Amifostine; D001374:Azacitidine